Martin McGlynn
2013
In 2013, Martin McGlynn earned a total compensation of $2.1M as Former Chief Executive Officer at StemCells, a 72% increase compared to previous year.
Compensation breakdown
| Bonus | $287,375 |
|---|---|
| Salary | $550,000 |
| Stock Awards | $1,239,000 |
| Other | $43,258 |
| Total | $2,119,633 |
McGlynn received $1.2M in stock awards, accounting for 58% of the total pay in 2013.
McGlynn also received $287.4K in bonus, $550K in salary and $43.3K in other compensation.
Rankings
In 2013, Martin McGlynn's compensation ranked 3,723rd out of 12,286 executives tracked by ExecPay. In other words, McGlynn earned more than 69.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,723 out of 12,286 | 70th |
Division Manufacturing | 1,267 out of 4,612 | 73rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 167 out of 681 | 76th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 102 out of 420 | 76th |
Industry Surgical and Medical Instruments and Apparatus | 53 out of 263 | 80th |
Source: SEC filing on April 8, 2016.
McGlynn's colleagues
We found three more compensation records of executives who worked with Martin McGlynn at StemCells in 2013.